Adverum nets $122.8M through FOPO

14:40 EST 13 Feb 2020 | Elsevier Business Intelligence

Adverum Biotechnologies Inc. (gene therapies for ocular and rare diseases) netted $122.8M through a follow-on public offering...

Original Article: Adverum nets $122.8M through FOPO


More From BioPortfolio on "Adverum nets $122.8M through FOPO"

Quick Search

Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...